ID HPS3_HUMAN Reviewed; 1004 AA. AC Q969F9; A8K6G6; Q8WTV6; Q96AP1; Q96MR3; Q9H608; DT 10-MAY-2002, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2001, sequence version 1. DT 19-JAN-2010, entry version 77. DE RecName: Full=Hermansky-Pudlak syndrome 3 protein; GN Name=HPS3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND INVOLVEMENT RP IN HPS3. RX MEDLINE=21372447; PubMed=11455388; DOI=10.1038/ng576; RA Anikster Y., Huizing M., White J.G., Shevchenko Y.O., RA Fitzpatrick D.L., Touchman J.W., Comptom J.G., Bale S.J., Swank R.T., RA Gahl W.A., Toro J.R.; RT "Mutation of a new gene causes a unique form of Hermansky-Pudlak RT syndrome in a genetic isolate of central Puerto Rico."; RL Nat. Genet. 28:376-380(2001). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE RP SEQUENCE [LARGE SCALE MRNA] OF 199-1004 (ISOFORMS 1 AND 2). RC TISSUE=Placenta, Small intestine, and Tongue; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., RA Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., RA Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., RA Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., RA Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., RA Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., RA Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., RA Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Kidney, and Lymph; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-996, AND MASS RP SPECTROMETRY. RX PubMed=17053785; DOI=10.1038/sj.emboj.7601384; RA Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A., RA Lottspeich F., Chen Z.; RT "Tyrosine phosphorylated Par3 regulates epithelial tight junction RT assembly promoted by EGFR signaling."; RL EMBO J. 25:5058-5070(2006). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-957 AND SER-960, AND RP MASS SPECTROMETRY. RX PubMed=18187866; DOI=10.2116/analsci.24.161; RA Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; RT "Automated phosphoproteome analysis for cultured cancer cells by two- RT dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; RL Anal. Sci. 24:161-166(2008). RN [7] RP VARIANT HPS3 TRP-397. RX MEDLINE=21473755; PubMed=11590544; DOI=10.1086/324168; RA Huizing M., Anikster Y., Fitzpatrick D.L., Jeong A.B., D'Souza M., RA Rausche M., Toro J.R., Kaiser-Kupfer M.I., White J.G., Gahl W.A.; RT "Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non- RT Puerto Rican patients with hypopigmentation and platelet storage-pool RT deficiency."; RL Am. J. Hum. Genet. 69:1022-1032(2001). RN [8] RP VARIANT [LARGE SCALE ANALYSIS] GLN-397. RX PubMed=16959974; DOI=10.1126/science.1133427; RA Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., RA Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., RA Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., RA Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C., RA Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., RA Vogelstein B., Kinzler K.W., Velculescu V.E.; RT "The consensus coding sequences of human breast and colorectal RT cancers."; RL Science 314:268-274(2006). CC -!- FUNCTION: Involved in early stages of melanosome biogenesis and CC maturation (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q969F9-1; Sequence=Displayed; CC Name=2; CC IsoId=Q969F9-2; Sequence=VSP_003878, VSP_003879; CC Note=No experimental confirmation available; CC -!- TISSUE SPECIFICITY: Widely expressed. Higher levels of expression CC are observed in kidney, liver and placenta. CC -!- DISEASE: Defects in HPS3 are the cause of Hermansky-Pudlak CC syndrome type 3 (HPS3) [MIM:203300]. Hermansky-Pudlak syndrome CC (HPS) is a genetically heterogeneous, rare, autosomal recessive CC disorder characterized by oculocutaneous albinism, bleeding due to CC platelet storage pool deficiency, and lysosomal storage defects. CC This syndrome results from defects of diverse cytoplasmic CC organelles including melanosomes, platelet dense granules and CC lysosomes. Ceroid storage in the lungs is associated with CC pulmonary fibrosis, a common cause of premature death in CC individuals with HPS. CC -!- WEB RESOURCE: Name=Mutations of the HPS3 gene; Note=Retina CC International's Scientific Newsletter; CC URL="http://www.retina-international.com/sci-news/hps3mut.htm"; CC -!- WEB RESOURCE: Name=Albinism database (ADB); Note=HPS3 mutations; CC URL="http://albinismdb.med.umn.edu/hps3mut.html"; CC -!- WEB RESOURCE: Name=GeneReviews; CC URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/HPS3"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF375663; AAK84131.1; -; Genomic_DNA. DR EMBL; AY033141; AAK53457.1; -; mRNA. DR EMBL; AK026357; BAB15459.1; -; mRNA. DR EMBL; AK056575; BAB71221.1; ALT_INIT; mRNA. DR EMBL; AK291631; BAF84320.1; -; mRNA. DR EMBL; CH471052; EAW78886.1; -; Genomic_DNA. DR EMBL; BC016901; AAH16901.1; ALT_INIT; mRNA. DR EMBL; BC022062; AAH22062.2; ALT_INIT; mRNA. DR EMBL; BC040359; AAH40359.1; -; mRNA. DR IPI; IPI00056324; -. DR IPI; IPI00220378; -. DR RefSeq; NP_115759.2; -. DR UniGene; Hs.558314; -. DR UniGene; Hs.591311; -. DR STRING; Q969F9; -. DR PhosphoSite; Q969F9; -. DR PRIDE; Q969F9; -. DR Ensembl; ENST00000296051; ENSP00000296051; ENSG00000163755; Homo sapiens. DR GeneID; 84343; -. DR KEGG; hsa:84343; -. DR UCSC; uc003ewu.1; human. DR CTD; 84343; -. DR GeneCards; GC03P150330; -. DR H-InvDB; HIX0003761; -. DR HGNC; HGNC:15597; HPS3. DR MIM; 203300; phenotype. DR MIM; 606118; gene. DR Orphanet; 79430; Hermansky-Pudlak syndrome. DR PharmGKB; PA29433; -. DR HOGENOM; HBG714744; -. DR HOVERGEN; Q969F9; -. DR InParanoid; Q969F9; -. DR OMA; PVSMDVC; -. DR OrthoDB; EOG9DNHQM; -. DR PhylomeDB; Q969F9; -. DR NextBio; 74133; -. DR ArrayExpress; Q969F9; -. DR Bgee; Q969F9; -. DR CleanEx; HS_HPS3; -. DR Genevestigator; Q969F9; -. DR GermOnline; ENSG00000163755; Homo sapiens. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR InterPro; IPR017216; BLOC-2_complex_Hps3_subunit. DR PIRSF; PIRSF037473; BLOC-2_complex_Hps3; 1. PE 1: Evidence at protein level; KW Albinism; Alternative splicing; Complete proteome; Cytoplasm; KW Disease mutation; Hermansky-Pudlak syndrome; Phosphoprotein; KW Polymorphism. FT CHAIN 1 1004 Hermansky-Pudlak syndrome 3 protein. FT /FTId=PRO_0000084050. FT MOTIF 172 176 Clathrin-binding (Potential). FT MOD_RES 957 957 Phosphotyrosine. FT MOD_RES 960 960 Phosphoserine. FT MOD_RES 996 996 Phosphotyrosine. FT VAR_SEQ 864 890 SLICGPSFDIASIIPFLEPLSEDTIAG -> LPLFRSWSHF FT QKTLLPASVSMFCVVHA (in isoform 2). FT /FTId=VSP_003878. FT VAR_SEQ 891 1004 Missing (in isoform 2). FT /FTId=VSP_003879. FT VARIANT 275 275 E -> K (in dbSNP:rs34388030). FT /FTId=VAR_038379. FT VARIANT 397 397 R -> Q (in a colorectal cancer sample; FT somatic mutation). FT /FTId=VAR_035928. FT VARIANT 397 397 R -> W (in HPS3; mild). FT /FTId=VAR_013251. FT CONFLICT 144 145 VK -> AR (in Ref. 4; AAH22062). FT CONFLICT 556 556 G -> E (in Ref. 2; BAB71221). FT CONFLICT 563 563 S -> T (in Ref. 4; AAH22062). SQ SEQUENCE 1004 AA; 113736 MW; ECA8FDF6AE37B47A CRC64; MVQLYNLHPF GSQQVVPCKL EPDRFCGGGR DALFVAAGCK VEAFAVAGQE LCQPRCAFST LGRVLRLAYS EAGDYLVAIE EKNKATFLRA YVNWRNKRTE NSRVCIRMIG HNVEGPFSKA FRDQMYIIEM PLSEAPLCIS CCPVKGDLLV GCTNKLVLFS LKYQIINEEF SLLDFERSLI IHIDNITPVE VSFCVGYVAV MSDLEVLIVK LESGPKNGER VHHHPHKTNN RIRRTEEGIS NEISQLESDD FVICQKPLEL LGEKSEQSGL SVTLESTGLA DEKRKYSHFQ HLLYRRFAPD ISSYVLSDDI KLHSLQLLPI YQTGSLTSDG KNLSQEKELL SLFCFFSLPH VGYLYMVVKS VELMSVYQYP EKSQQAVLTP QFLHVITSNN LQCFTVRCSA AAAREEDPYM DTTLKACPPV SMDVCALRIQ LFIGLKAICH FKNHIILLTK AEPEAIPERR QSPKRLLSRK DTSVKIKIPP VAEAGWNLYI VNTISPVQLY KEMVDYSNTY KTVKTQSCIH LLSEAHLLVR AALMDASQLE PGEKAELLEA FKESCGHLGD CYSRLDSQHS HLTLPYYKMS GLSMAEVLAR TDWTVEDGLQ KYERGLIFYI NHSLYENLDE ELNEELAAKV VQMFYVAEPK QVPHILCSPS MKNINPLTAM SYLRKLDTSG FSSILVTLTK AAVALKMGDL DMHRNEMKSH SEMKLVCGFI LEPRLLIQQR KGQIVPTELA LHLKETQPGL LVASVLGLQK NNKIGIEEAD SFFKVLCAKD EDTIPQLLVD FWEAQLVACL PDVVLQELFF KLTSQYIWRL SKRQPPDTTP LRTSEDLINA CSHYGLIYPW VHVVISSDSL ADKNYTEDLS KLQSLICGPS FDIASIIPFL EPLSEDTIAG LSVHVLCRTR LKEYEQCIDI LLERCPEAVI PYANHELKEE NRTLWWKKLL PELCQRIKCG GEKYQLYLSS LKETLSIVAV ELELKDFMNV LPEDGTATFF LPYLLYCSRK KPLT //